Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Exscientia Plc EXAI

Exscientia PLC is an artificial intelligence-driven pharma tech company committed to discovering, designing, and developing drugs. Its patient-first AI process is comprised of Precision Target, Precision Design, Precision Experiment, and Precision Medicine. Its revenue is generated from Service fees related to drug discovery collaboration agreements it is utilizing its proprietary technology to develop novel Intellectual Property (IP); and Licensing fees related to drug discovery agreements.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:Interesting new entrant to the AI PubCo space

BTW Re: V.DM here's a little Due Diligence I can share for any interested in taking a peep: https://traffic.libsyn.com/secure/bellpodcast/Bullseye_Brief_Ep119_Marshall_Gunter.mp3  ...read more

Interesting new entrant to the AI PubCo space

I'm comfortable with the size of my position I now have built in : https://www.datametrex.com/ But because of my position and due diligence in V.DM I have now become aware of how huge the AI...read more